6-42173531-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_001384910.1(GUCA1A):c.-83G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.123 in 1,122,758 control chromosomes in the GnomAD database, including 10,390 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.17 ( 2819 hom., cov: 33)
Exomes 𝑓: 0.12 ( 7571 hom. )
Consequence
GUCA1A
NM_001384910.1 5_prime_UTR
NM_001384910.1 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.45
Genes affected
GUCA1A (HGNC:4678): (guanylate cyclase activator 1A) This gene encodes an enzyme that plays a role in the recovery of retinal photoreceptors from photobleaching. This enzyme promotes the activity of retinal guanylyl cyclase-1 (GC1) at low calcium concentrations and inhibits GC1 at high calcium concentrations. Mutations in this gene can cause cone dystrophy 3 and code-rod dystrophy 14. provided by RefSeq, Jul 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 6-42173531-G-A is Benign according to our data. Variant chr6-42173531-G-A is described in ClinVar as [Benign]. Clinvar id is 356690.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.312 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GUCA1A | NM_001384910.1 | c.-83G>A | 5_prime_UTR_variant | 1/4 | ENST00000372958.2 | NP_001371839.1 | ||
GUCA1ANB-GUCA1A | NM_001319061.2 | c.-83G>A | 5_prime_UTR_variant | 3/6 | NP_001305990.1 | |||
GUCA1ANB-GUCA1A | NM_000409.5 | c.-83G>A | 5_prime_UTR_variant | 3/6 | NP_000400.2 | |||
GUCA1ANB-GUCA1A | NM_001319062.2 | c.-83G>A | 5_prime_UTR_variant | 2/5 | NP_001305991.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GUCA1A | ENST00000372958.2 | c.-83G>A | 5_prime_UTR_variant | 1/4 | 1 | NM_001384910.1 | ENSP00000362049 | P1 |
Frequencies
GnomAD3 genomes AF: 0.166 AC: 25300AN: 152092Hom.: 2816 Cov.: 33
GnomAD3 genomes
AF:
AC:
25300
AN:
152092
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.116 AC: 112801AN: 970548Hom.: 7571 Cov.: 13 AF XY: 0.116 AC XY: 58238AN XY: 503156
GnomAD4 exome
AF:
AC:
112801
AN:
970548
Hom.:
Cov.:
13
AF XY:
AC XY:
58238
AN XY:
503156
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.166 AC: 25320AN: 152210Hom.: 2819 Cov.: 33 AF XY: 0.163 AC XY: 12103AN XY: 74416
GnomAD4 genome
AF:
AC:
25320
AN:
152210
Hom.:
Cov.:
33
AF XY:
AC XY:
12103
AN XY:
74416
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
204
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Cone dystrophy 3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at